Global Price and Market Access Director

AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines for some of the world’s most serious diseases. 

ONCOLOGY BUSINESS UNIT 

We’re all here to make an impact – to achieve our bold ambition of eliminating cancer as a cause of death. 

In the Oncology Business Unit we relentlessly follow the science, challenging the status quo to deliver more effective treatments to patients in need. Our commitment means we purposefully push back the limits of knowledge to change the practice of medicine. To ensure no patient is left behind, no matter what stage of disease. 

WHY JOIN MARKET ACCESS AT ASTRAZENECA? 

Join a highly valued, strategic team that is fundamental in realizing the potential of our life-changing medicines. It’s through our work that AstraZeneca is able to ensure the right access is provided to our transformative medicines. 

Working with new drugs, new treatment modalities, new digital approaches and ever-changing environments, it’s crucial that we remain flexible and on top of the detail. Running, thinking and acting fast to make smart decisions and get the right medicines to patients at the right time. 

We lead the way for the industry with our pioneering valued-based agreements and Innovative Value Strategy solutions. It’s our determination and unwavering belief in the power of our medicines, and the science sitting behind them, that drives us to ensure their value is realized. 

Inspired by our people, patients and pipeline, we work cross-functionally to leverage our shared skills, knowledge and entrepreneurial spirit to change the way medicines are assessed and perceived, and turn ambitions into reality. 

We’re pioneering Market Access innovations: this is the place to unlock opportunities and feed our love for the challenge. United by an unrivalled passion for patients and science and always performing at the top of our game. 

GLOBAL PRICING AND MARKET ACCESS DIRECTOR – WHAT YOU’LL DO: 

Be part of solid tumor early assets Oncology Market Access and Pricing (OMAP) team , leading on new technology assets including cell therapy –autologous, in-vivo and allogeneic and radioconjugates working in collaboration with early assets team including P&MA and Health Economics and Payer Evidence teams at the global, regional and local level. You will also represent OMAP on relevant Global project teams (GPTs) and where established Integrated Business Teams (IBTs) working with colleagues from brand strategy, commercial, regulatory, R&D and clinical teams.  

Responsibilities will include: 

• Global Price and Market Access Strategy for Early Assets incl business development 

• Robust pricing inputs and assumptions for investment decisions and internal forecasts with line of sight to commercialisation and ensure assumptions are aligned across the portfolio. 

• Provide input and guidance on early Clinical Development Plans  

• Provide input and guidance on regulatory trial designs, target product profiles and endpoints vs payer needs  

• Develop national to regional to local access insights for cell and radio conjugates across geographies working in collaboration with AZ regional and country teams.